Autoantibody Production in Cancer - The Humoral Immune Response toward Autologous Antigens in Cancer Patients

P. Zaenker, E.S. Gray, Melanie R. Ziman

    Research output: Contribution to journalReview article

    42 Citations (Scopus)

    Abstract

    © 2016 The Authors.A link between autoimmune responses and cancer via autoantibodies was first described in the 1950s. Since, autoantibodies have been studied for their potential use as cancer biomarkers, however the exact causes of their production remain to be elucidated. This review summarizes current theories of the causes of autoantibody production in cancer, namely: 1) defects in tolerance and inflammation, 2) changes in protein expression levels, 3) altered protein structure, and 4) cellular death mechanisms. We also highlight the need for further research into this field to improve our understanding of autoantibodies as biomarkers for cancer development and progression.
    Original languageEnglish
    Pages (from-to)477-483
    Number of pages7
    JournalAutoimmunity Reviews
    Volume15
    Issue number5
    DOIs
    Publication statusPublished - 2016

    Fingerprint

    Autoantigens
    Humoral Immunity
    Autoantibodies
    Tumor Biomarkers
    Neoplasms
    Cellular Structures
    Autoimmunity
    Proteins
    Inflammation
    Research

    Cite this

    @article{5541a7c4b31343158dfb325cd26ff6e3,
    title = "Autoantibody Production in Cancer - The Humoral Immune Response toward Autologous Antigens in Cancer Patients",
    abstract = "{\circledC} 2016 The Authors.A link between autoimmune responses and cancer via autoantibodies was first described in the 1950s. Since, autoantibodies have been studied for their potential use as cancer biomarkers, however the exact causes of their production remain to be elucidated. This review summarizes current theories of the causes of autoantibody production in cancer, namely: 1) defects in tolerance and inflammation, 2) changes in protein expression levels, 3) altered protein structure, and 4) cellular death mechanisms. We also highlight the need for further research into this field to improve our understanding of autoantibodies as biomarkers for cancer development and progression.",
    author = "P. Zaenker and E.S. Gray and Ziman, {Melanie R.}",
    year = "2016",
    doi = "10.1016/j.autrev.2016.01.017",
    language = "English",
    volume = "15",
    pages = "477--483",
    journal = "Autoimmunity Reviews",
    issn = "1568-9972",
    publisher = "Elsevier",
    number = "5",

    }

    Autoantibody Production in Cancer - The Humoral Immune Response toward Autologous Antigens in Cancer Patients. / Zaenker, P.; Gray, E.S.; Ziman, Melanie R.

    In: Autoimmunity Reviews, Vol. 15, No. 5, 2016, p. 477-483.

    Research output: Contribution to journalReview article

    TY - JOUR

    T1 - Autoantibody Production in Cancer - The Humoral Immune Response toward Autologous Antigens in Cancer Patients

    AU - Zaenker, P.

    AU - Gray, E.S.

    AU - Ziman, Melanie R.

    PY - 2016

    Y1 - 2016

    N2 - © 2016 The Authors.A link between autoimmune responses and cancer via autoantibodies was first described in the 1950s. Since, autoantibodies have been studied for their potential use as cancer biomarkers, however the exact causes of their production remain to be elucidated. This review summarizes current theories of the causes of autoantibody production in cancer, namely: 1) defects in tolerance and inflammation, 2) changes in protein expression levels, 3) altered protein structure, and 4) cellular death mechanisms. We also highlight the need for further research into this field to improve our understanding of autoantibodies as biomarkers for cancer development and progression.

    AB - © 2016 The Authors.A link between autoimmune responses and cancer via autoantibodies was first described in the 1950s. Since, autoantibodies have been studied for their potential use as cancer biomarkers, however the exact causes of their production remain to be elucidated. This review summarizes current theories of the causes of autoantibody production in cancer, namely: 1) defects in tolerance and inflammation, 2) changes in protein expression levels, 3) altered protein structure, and 4) cellular death mechanisms. We also highlight the need for further research into this field to improve our understanding of autoantibodies as biomarkers for cancer development and progression.

    U2 - 10.1016/j.autrev.2016.01.017

    DO - 10.1016/j.autrev.2016.01.017

    M3 - Review article

    VL - 15

    SP - 477

    EP - 483

    JO - Autoimmunity Reviews

    JF - Autoimmunity Reviews

    SN - 1568-9972

    IS - 5

    ER -